Clinical Safety and Scar Prevention Study of a Topical Antifibrotic Compound FS2.
Conditions: Scar; Cicatrix; Hypertrophic Scar; Skin Graft Scar; Skin Graft Complications; Donor Site Complication; Keloid Interventions: Drug: Fibrosis-Inhibiting-Compound-FS2; Other: Vehicle moisture balancing base Sponsor: University of British Columbia Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials